Abstract

Precision medicine is an approach to prevent and treat diseases that takes into account people’s individual variations in genes, environment, and lifestyle. The current Precision Medicine Initiative of the US Government is to “generate the scientific evidence needed to move the concept of precision medicine into clinical practice”. In the first approximation, precision medicine may provide a more accurate diagnosis of the disease such as cancer, but may not have the means to offer an improved therapy. The aim of drug targeting is to generate pharmacologically effective drug concentration at the site of disease while keeping a very low/minimal drug concentration in the rest of the body, away from the site of disease. Targeted drugs are thus “precision drugs” needed to bring precision medicine into the clinical practice. Focusing on the area of cancer therapy, this review examines the essential requirements that must be met for cell/tumour-targeted drug-delivery systems to work. It examines the progress to date and draws conclusions for an optimal paradigm for future drug-delivery systems development.

Highlights

  • Precision Medicine is a medical-research area that recently attracted headline attention when President Obama announced a $US215 million initiative to amass genetic data on some 1 million Americans, with the aim of “discovering genetic causes of disease and finding new drugs that will target dangerous mutations” [1].The aim of precision medicine is to take into account people’s individual variations in genes, environment, and lifestyle when treating diseases

  • The current precision-medicine initiative of the US Government is to “generate the scientific evidence needed to move the concept of precision medicine into clinical practice” [2,3]

  • The above overview suggests that the most plausible paradigm for the future development of site-specific drug-delivery systems is to combine monoclonal antibodies with drugs that meet the pharmacokinetic and pharmacodynamic requirements of this application

Read more

Summary

Introduction

Precision Medicine is a medical-research area that recently attracted headline attention when President Obama announced a $US215 million initiative to amass genetic data on some 1 million Americans, with the aim of “discovering genetic causes of disease and finding new drugs that will target dangerous mutations” [1].The aim of precision medicine is to take into account people’s individual variations in genes, environment, and lifestyle when treating diseases. Focusing on the area of cancer therapy, this review examines the essential requirements that must be met for cell/tumour-targeted drug-delivery systems to work. Targeting cells in which a precisely diagnosed mechanism drives disease such as for example any particular cancer will very likely need “precision drugs” / “precision medications” that are yet to be developed.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.